2021 annual financial data
Aligos Therapeutics 2021 Operating cash flow
Aligos Therapeutics 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -115,662,000 USD.
Operating income was -128,321,000 USD and net income was -128,332,000 USD.
Operating cash flow was -115,662,000 USD.
Get free Aligos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,359,000 USD
- Operating income
- -128,321,000 USD
- Net income
- -128,332,000 USD
- Operating cash flow
- -115,662,000 USD